SEB Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468M Buy
390,198
+2,926
+0.8% +$2.99M 1.76% 10
2026
Q1
$356M Buy
+387,272
New +$393M 1.52% 10

Other funds holding LLY

SEB Asset Management's LLY Position: Q2 2026 in Review

SEB Asset Management increased its Eli Lilly (LLY) stake by 0.76% in Q2 2026, buying an estimated $2.99M and bringing the position to 390,198 shares worth $468M. The position accounts for 1.76% of the portfolio, ranked #10.

SEB Asset Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SEB Asset Management held 390,198 shares of Eli Lilly worth $468M as of Q2 2026.
  • SEB Asset Management bought 2,926 Eli Lilly shares in Q2 2026, an estimated $2.99M.
  • Eli Lilly made up 1.76% of SEB Asset Management's portfolio in Q2 2026, its #10 holding.
  • SEB Asset Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.